Keystone Financial Planning Inc. maintained its stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,768 shares of the company’s stock at the end of the second quarter. Keystone Financial Planning Inc.’s holdings in Cardinal Health were worth $527,000 as of its most recent filing with the SEC.

Other hedge funds have also recently made changes to their positions in the company. DnB Asset Management AS raised its stake in shares of Cardinal Health by 19.7% in the first quarter. DnB Asset Management AS now owns 37,083 shares of the company’s stock worth $3,024,000 after buying an additional 6,100 shares during the last quarter. Capital Investment Advisors LLC increased its position in shares of Cardinal Health by 3.3% in the first quarter. Capital Investment Advisors LLC now owns 6,187 shares of the company’s stock worth $505,000 after buying an additional 196 shares during the period. Farmers & Merchants Investments Inc. increased its position in shares of Cardinal Health by 59.0% in the first quarter. Farmers & Merchants Investments Inc. now owns 40,639 shares of the company’s stock worth $3,314,000 after buying an additional 15,077 shares during the period. Donald L. Hagan LLC increased its position in shares of Cardinal Health by 8.3% in the first quarter. Donald L. Hagan LLC now owns 14,253 shares of the company’s stock worth $1,162,000 after buying an additional 1,087 shares during the period. Finally, CWM LLC increased its position in shares of Cardinal Health by 15.6% in the first quarter. CWM LLC now owns 331,531 shares of the company’s stock worth $27,036,000 after buying an additional 44,689 shares during the period. 87.09% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Cardinal Health, Inc. (NYSE:CAH) opened at 66.98 on Friday. The stock’s 50 day moving average price is $75.67 and its 200 day moving average price is $76.86. The company has a market cap of $21.17 billion, a P/E ratio of 16.62 and a beta of 0.80. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $84.88.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.07. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter last year, the business posted $1.14 EPS. The business’s revenue was up 5.0% on a year-over-year basis. On average, analysts forecast that Cardinal Health, Inc. will post $4.97 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a $0.4624 dividend. This represents a $1.85 annualized dividend and a dividend yield of 2.76%. The ex-dividend date is Friday, September 29th. Cardinal Health’s dividend payout ratio is currently 45.79%.

ILLEGAL ACTIVITY WARNING: “Cardinal Health, Inc. (NYSE:CAH) Position Maintained by Keystone Financial Planning Inc.” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.watchlistnews.com/cardinal-health-inc-nysecah-position-maintained-by-keystone-financial-planning-inc/1478355.html.

A number of equities analysts have recently issued reports on the company. William Blair downgraded Cardinal Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 19th. Jefferies Group LLC assumed coverage on Cardinal Health in a research report on Wednesday, May 17th. They set a “hold” rating and a $77.00 price objective for the company. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Zacks Investment Research upgraded Cardinal Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 20th. Finally, Vetr upgraded Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price objective for the company in a research report on Tuesday, June 13th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $80.46.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.